Related Experiment Video
Updated: Apr 16, 2026
13:44
Project-Based Learning Guidelines for Health Sciences Students: An Analysis with Data Mining and Qualitative Techniques
Published on: December 9, 2022
4.6K
A qualitative analysis of common concerns about challenges facing pharmacy experiential education programs
Jennifer Danielson1, Karen Craddick2, Dayl Eccles3
1University of Washington School of Pharmacy, Seattle, Washington.
American Journal of Pharmaceutical Education
|March 6, 2015
Summary
Pharmacy experiential education (EE) programs face persistent challenges with student placement capacity. Emerging concerns include preceptor development and student onboarding, requiring attention as accreditation standards evolve.
Area of Science:
- Pharmacy Education
- Experiential Learning
- Qualitative Research
Background:
- Pharmacy experiential education (EE) is crucial for training future pharmacists.
- Previous surveys identified general issues, but a deeper qualitative analysis was needed.
- Understanding current challenges is vital for program improvement and accreditation.
Purpose of the Study:
- To qualitatively analyze free-text responses from pharmacy EE directors.
- To systematically identify and categorize common concerns facing EE programs.
- To inform strategies for addressing challenges in pharmacy education.
Main Methods:
- Thematic analysis of open-ended survey responses from 78 US pharmacy schools.
- Iterative coding by expert and novice investigators to identify common themes.
- Validation of findings through independent reviewer coding and Cohen kappa analysis.
Main Results:
- Key concerns identified include site capacity, workload, financial support, quality assurance, preceptor development, stipends, assessment, and onboarding.
- Site capacity remains the primary issue for many programs.
- Preceptor development and student onboarding have emerged as significant new concerns.
Conclusions:
- Site capacity is the foremost concern for pharmacy experiential education programs.
- Preceptor development and student onboarding processes require immediate attention.
- Addressing these emerging issues is critical for adapting to new accreditation standards.
Related Concept Videos
01:19Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
228
Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...
228
01:26Pharmaceutical Poisoning: Potential Scenarios
102
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
102
01:19Pharmacovigilance
2.0K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
2.0K
01:10Qualitative Analysis
1.9K
Qualitative analysis is the process of identifying elements, ions, or compounds in an unknown sample. It is the first and most fundamental type of analysis based on the hierarchy of analytical goals. This hierarchy is significant as it provides a structured approach to scientific research, with qualitative analysis serving as the initial step, providing essential information before moving on to quantitative or other forms of analysis.
There are two main approaches to qualitative analysis:...
There are two main approaches to qualitative analysis:...
1.9K
01:26Drug Administration and Therapy Phases: Overview
2.1K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
2.1K
01:12Analysis of Population Pharmacokinetic Data
953
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
953